The ASIPP Guidelines on Biologics in Pain Medicine

Dr. Rosenblum reviews Key Points in the 2019 ASIPP's Biologics in Pain   Medicine Guidelines New PainExam Discount Valid until April 19th, 2019 Enter EPASPRING19 at Checkout on  PainExam.com Don't Lose your Anesthesia Skills Stay Up to Date with New Anesthesia Lectures at the AnesthesiaExam Podcast App Subscribe Now!     Subscribe to our mailing list * indicates required Email Address *     References Regenerative Medicine Guidelines Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines Pain physician 2019; 2019;22;S1-S74. Year Updated 2019   Annu Navani, MD, Laxmaiah Manchikanti, MD, Sheri L. Albers, DO, Richard E. Latchaw, MD, Jaya Sanapati, MD, Alan D. Kaye, MD, PhD, Sairam Atluri, MD,Sheldon Jordan, MD, Ashim Gupta, PhD, MBA, David Cedeno, PhD, Alejandro Vallejo, BS, Bert Fellows, MA, Nebojsa Nick Knezevic, MD, PhD, Miguel Pappolla, MD, Sudhir Diwan, MD, Andrea M. Trescot, MD, Amol Soin, MD, Adam M. Kaye, PharmD, FASCP, FCPhA, Steve M. Aydin, DO, Aaron K. Calodney, MD, Kenneth D. Candido, MD, Sanjay Bakshi, MD, Ramsin M. Benyamin, MD, Ricardo Vallejo, MD, PhD, Art Watanabe, MD, Douglas Beall, MD, Todd P. Stitik, MD, Patrick M. Foye, MD, Erik M. Helander, MBBS, and Joshua A. Hirsch, MD